<DOC>
	<DOCNO>NCT02416804</DOCNO>
	<brief_summary>Major purpose research evaluate effect usefulness Buprenorphine transdermal system ( MTDS ) among patient lumbar spinal disease perform single-level posterior lumbar fusion . After surgery , patient apply patient-controlled analgesia . After three day surgery , patient divide two groups.Group A experimental group administer BTDS surgery , Group B control group take tramadol analgesic . If patient 's pain score exceed NRS 4 , take additional rescue medicine , acetaminophen . After surgery , patient 's pain score quality life would record sequentially . The time record postoperative 36 hour , 72 hour , 7 day , 2 week , 4 week , 3 month , respectively .</brief_summary>
	<brief_title>Postoperative Analgesia With Buprenorphine Postoperative Pain Control Quality Life After Spinal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>adult 20 year take lumbar spinal surgery : singlelevel , posterior fusion stay hospital 2 day operation pregnancy breastfeed allergy contraindication buprenorphine patient decrease lung function patient take MAO inhibitor anticonvulsant patient brain lesion , severe liver disease dependence opioid drug take muscle relaxant tranquilizer patient take buprenorphine preoperatively take strong opioids enrol study another severe source pain except lumbar spine severe cardiovascular , pulmonary , renal compromise patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>buprenorphine</keyword>
	<keyword>transdermal system</keyword>
	<keyword>Pain , postoperative</keyword>
	<keyword>Quality life</keyword>
	<keyword>Spinal stenosis</keyword>
	<keyword>Posterior lumbar fusion</keyword>
</DOC>